Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
152.50
+3.13 (2.10%)
At close: Feb 6, 2026, 4:00 PM EST
152.22
-0.28 (-0.18%)
After-hours: Feb 6, 2026, 7:59 PM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
The 21 analysts that cover Gilead Sciences stock have a consensus rating of "Buy" and an average price target of $130.1, which forecasts a -14.69% decrease in the stock price over the next year. The lowest target is $96 and the highest is $156.
Price Target: $130.1 (-14.69%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 7 | 8 | 8 |
| Buy | 12 | 10 | 10 | 9 | 9 | 9 |
| Hold | 6 | 6 | 5 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 22 | 22 | 20 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $140 → $145 | Strong Buy | Maintains | $140 → $145 | -4.92% | Jan 27, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $140 → $156 | Strong Buy | Maintains | $140 → $156 | +2.30% | Jan 27, 2026 |
| UBS | UBS | Strong Buy Maintains $145 → $155 | Strong Buy | Maintains | $145 → $155 | +1.64% | Jan 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $151 → $150 | Buy | Maintains | $151 → $150 | -1.64% | Jan 13, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $135 → $140 | Strong Buy | Maintains | $135 → $140 | -8.20% | Jan 7, 2026 |
Financial Forecast
Revenue This Year
29.81B
from 28.75B
Increased by 3.66%
Revenue Next Year
30.80B
from 29.81B
Increased by 3.32%
EPS This Year
8.32
from 0.38
Increased by 2,089.66%
EPS Next Year
8.93
from 8.32
Increased by 7.35%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 31.2B | 32.8B | ||||
| Avg | 29.8B | 30.8B | ||||
| Low | 28.0B | 28.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.5% | 10.1% | ||||
| Avg | 3.7% | 3.3% | ||||
| Low | -2.5% | -4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.72 | 9.98 | ||||
| Avg | 8.32 | 8.93 | ||||
| Low | 7.86 | 6.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2,193.7% | 19.9% | ||||
| Avg | 2,089.7% | 7.3% | ||||
| Low | 1,968.3% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.